INTRODUCTION
The second messenger adenosine 3',5'-cyclic monophosphate (CAMP) mediates the modulatory actions of a wide variety of transmitters and hormones on neuronal membrane currents (Kaczmarek and Levitan 1987; Levitan 1985 Levitan , 1988 Siegelbaum and Tsien 1983) . Since the discovery that forskolin can activate adenylate cyclase in intact cells (Metzger and Linder 198 1; Seamon and Daly 198 l) , it has become a major tool for implicating CAMP as an intermediary in the modulation of membrane current. Forskolin increases intracellular levels of CAMP by acting directly at the catalytic subunit of the adenylate cyclase (for review see Seamon and Daly 1986) . The activation of adenylate cyclase by forskolin does not require agonist binding to receptors, guanine nucleotide regulatory proteins, or guanine nucleotides (Seamon and Daly 1986) . In addition, forskolin does not activate or inhibit other enzymes involved in cyclic nucleotide metabolism, including guanylate cyclase and cyclic nucleotide phosphodiesterases (Seamon and Daly 1986) . Thus, in studies relating CAMP to the modulation of membrane current, the effects of forskolin on membrane current have been assumed to result solely from activation of adenylate cyclase and increases in the levels of intracellular CAMP.
Several recent studies indicate that forskolin can have direct effects on ion channels that are not mediated via CAMP (Laurenza et al. 1989) . For example, forskolin reduces the amplitude and alters the kinetics of the transient IV current (IA) in neurons of nudibranch molluscs (Coombs and Thompson 1987) . These actions of forskolin on 1* were not mimicked by intracellular injection of CAMP, by application of membrane-permeable analogues of CAMP, by application of phosphodiesterase inhibitors, or by injection of the catalytic subunit of CAMP-dependent protein kinase (PKA). Similarly, forskolin alters the kinetics of the voltage-dependent K+ current (Zk v) in neurons of Hefix, but this effect is not mimicked by injection of CAMP (Watanabe and Gola 1987) . Forskolin also decreases a voltage-dependent K+ current in PC12 cells (Hoshi et al. 1988 ). This effect of forskolin is not mimicked by an analogue of CAMP or by phosphodiesterase inhibitors. Moreover, this effect of forskolin is observed in cellfree patches independent of soluble cytoplasmic enzymes. In addition, a derivative of forskolin that is unable to activate adenylate cyclase ( 1,9-dideoxy-forskolin) (Bhat et al. 1983; Seamon et al. 1983; Seamon and Daly 1986 ) also reduces the K+ current (Hoshi et al. 1988) . In somata of neurons in lobsters, both forskolin and 1,9-dideoxy-forskolin reduce 1*, but an analogue of CAMP does not mimic this effect (Harris-Warrick 1988) . Finally, both forskolin and 1,9-dideoxy-forskolin block the nicotinic-receptormediated influx of Na+ and Ca2+ in PC12 cells, but an analogue of CAMP does not mimic this effect (Nishizawa et al. 1989 ). These results indicate that forskolin, and certain of its derivatives, can have direct actions on membrane current that are independent of CAMP.
In this study we compare the effects of analogues of CAMP with the effects of forskolin and two of its derivatives on K+ currents in somata of sensory neurons isolated from pleural ganglia of Aplysia. Previous work has shown that, in these sensory neurons, elevated levels of intracellular CAMP result in the suppression of at least one K+ current, which is activated by relatively brief voltage-clamp pulses; the serotonin-sensitive K+ current (1k s) (Baxter and Byrne 1989; Belardetti et al. 1987; Brezina et al. 1987; Pollock et al. 1985; Scholz and Byrne 1988; Walsh and Byrne 1989) . We found that bath application of an analogue of CAMP reduced I k,s but that it did not reduce the peak amplitude of either 1* or 1k v. In contrast, bath application of forskolin reduced the amplitude of 1* and 1k v. Furthermore, 1,9-dideoxy-forskolin mimicked the actions of forskolin and reduced the amplitude of both IA and Ik v. We found, however, that a modified form of forskolin , which has enhanced water solubility and activates adenylate cyclase (Laurenza et al. 1987) , mimicked the actions of analogues of CAMP and reduced Ik,s, but it did not affect the amplitude of either IA or I k,v. These results support the conclusion that forskolin has direct actions on membrane channels that are not mediated via CAMP; thus the usefulness of forskolin in studies of CAMP-mediated modulation of membrane current is limited. However, the results demonstrate that certain hydrophilic derivatives of forskolin, which retain the ability to stimulate adenylate cyclase, do not have some of the nonspecific actions that are associated with forskolin. Preliminary reports of these results have been presented Byrne 1985, 1988) .
METHODS
All experiments were performed on clusters of somata of sensory neurons that were surgically isolated from the ventrocaudal clusters of pleural ganglia in ApZysia cahfornica. The methods for isolating, voltage clamping, and applying drugs to these sensory neurons have been described in detail previously (Baxter and Byrne 1989) . Dissections were performed after anesthetizing the animals by injection of a volume of isotonic MgC12 equal to about one-half of the animal's volume. The isolated clusters were pinned to the silicone elastomer (Sylgard)-coated (Dow-Corning) floor of an experimental chamber with a volume of 300 ~1. The static bathing solution of artificial seawater (ASW; Instant Ocean, Aquarium Systems, Mentor, OH) was buffered to pH 7.6 with 10 mM Trizma (Sigma) and also contained 150 PM tetrodotoxin (TTX; Sigma). In some experiments 1 mM tetraethylammonium (TEA) also was added to the ASW to reduce the Ca2+-activated K+ current (lkCa). During all experiments the bath temperature was maintained at 15 k 1 "C by a thermoelectric cooling unit placed under the experimental chamber.
Conventional two-electrode voltage-clamp techniques (Axoclamp-2 amplifier; Axon Instruments) were used to compare the effects of bath application of analogues of CAMP with the effects of forskolin or its derivatives on current responses that were elicited by brief depolarizing voltage-clamp pulses. Somata of sensory neurons were impaled with two glass capillary microelectrodes that were filled with 3 M potassium acetate and that had resistances of 2-6 MQ. Current responses were elicited by 200-ms voltage-clamp pulses that were preceded by a 25-s hyperpolarizing prepulse to either -50 or -90 mV. The voltage-clamp pulses were separated by 90 s and were incremented in steps of 10 mV to membrane potentials ranging between -40 and +30 mV. After the 200-ms voltage-clamp pulse, the membrane potential was stepped back to -50 mV for 500 ms. Between voltage-clamp pulses, the cells were returned to their resting membrane potential. The current responses and a calibration pulse were digitized and displayed on-line (500 samples at 1.67 kHz, 12-bit resolution) with a microcomputer and were stored for later analysis. A minimum of three stable current responses were obtained at each voltage in the series of voltage-clamp pulses before and after bath application of each compound. The stable responses were averaged, off-line, for each potential in the series of voltage-clamp pulses. Although the membrane voltages during the voltageclamp pulses were not digitized, they were monitored constantly. Current responses were accepted only if the step changes in membrane voltage were completed in < 1 ms and no voltage "sag" was detected. No compensation for series resistance was used (Baxter and Byrne 1989) .
Two membrane-permeable and phosphodiesterase-resistant analogues of CAMP were used, either 8-bromo-CAMP (8br-CAMP; Sigma) or 8-4-parachlorophenylthio-CAMP (8-pcpt-CAMP; Sigma) (Meyers and Miller 1974; Miller et al. 1980; Simon et al. 1973) . Typically, bath concentrations of 1 mM 8-br-CAMP or 100 PM 8-pcpt-CAMP were used in this study. The two analogues of CAMP had similar effects (n = 22 for 8-br-CAMP; n = 15 for 8-pcpt-CAMP), and therefore the results have been combined and are referred to simply as analogues of CAMP.
Forskolin and two derivatives of forskolin were obtained from Calbiochem (San Diego, CA). Forskolin (7@-acetoxy-8,13-epoxy-1 a,6&9ar-trihydroxy-labd-14-ene-11 -one) activates almost all forms of mammalian adenylate cyclases with a potency in the micromolar range (Seamon and Daly 1986) . In molluscan neurons forskolin has been reported to evoke a three-to ninefold enhancement in the activation of adenylate cyclase at concentrations between 20 and 100 PM (Deterre et al. 1982; Kauer and Kaczmarek 1985) . Typically, a bath concentration of 50 PM forskolin was used in this study. In addition to forskolin, two derivatives of forskolin were used in this study: 7-deacetyl-6-[N-acetylglycyll-forskolin, a form of forskolin with enhanced water solubility and the ability to activate adenylate cyclase (Bhat et al. 1983; Laurenza et al. 1987; Seamon et al. 1983; Seamon and Daly 1986) . 1,9-Dideoxy-forskolin is a form of forskolin that does not activate adenylate cyclase (Bhat et al. 1983; Seamon et al. 1983; Seamon and Daly 1986) . Typically, bath concentrations of 100 PM 7-deacetyl-6-[N-acetylglycyll-forskolin, or 50 PM 1,9-dideoxy-forskolin were used.
All solutions were made immediately before each experiment. Usually, 8-br-CAMP was dissolved directly into ASW. Forskolin, 1,9-dideoxy-forskolin, and 8-pcpt-CAMP, however, have limited water solubility. Therefore forskolin, its derivatives, and 8-pcpt-CAMP first were dissolved in dimethyl sulfoxide (DMSO; Sigma), and then ASW was added to aliquots of these DMSO solutions to make the stock solutions. Small aliquots of the stock solutions were added directly to the experimental chamber to obtain the desired final concentration of each compound. The final concentration of DMSO in the bath never exceeded 0.75% (v/v). (Although 7-deacetyl-6-[N-acetylglycyll-forskolin has enhanced solubility in water, dissolving it in DMSO provided one method of controlling for the contributions of the DMSO to the observed differential effects on current responses of forskolin, 8-pcpt-CAMP, and 7-deacetyl-6-[N-acetylglycyll-forskolin.) The results presented in this paper represent successful recordings from 81 cells. These cells had an average input resistance of 29 to.9 MQ (SEM) and had an average resting membrane potential-of -45 mV (kO.4).
RESULTS

Reduction of IA bv forskolin not mediated via CAMP
To determine whether CAMP or forskolin affected the fast, transient K+ current (IA), we isolated examples of IA first in ASW and again after bath application of either an analogue of CAMP or forskolin. An example of the method used to isolate IA is shown in Fig. 1 In contrast to the effect of the analogue of CAMP, forskolin dramatically reduced the peak amplitude of Z* (Fig.  1B) . Current responses were elicited by voltage-clamp pulses to -20 mV from holding potentials of -90 and -50 mV, first in ASW (Fig. 1 Bl) and again after bath application of forskolin (Fig. 1 B3) . A comparison of Z*, which was isolated in ASW ( Fig. 1 B2) , with Z*, which was isolated in FIG. 1. Analogues of CAMP did not mimic the effect of forskolin on the fast, transient K+ current (IA) . Al: current responses were elicited in ASW by voltage-clamp pulses to -20 mV from holding potentials of -50 and -90 mV. Holding potential of -50 mV inactivated the transient outward current (IA) that was elicited by the voltage-clamp pulse from the holding potential of -90 mV. A2: IA was isolated by subtracting the current response elicited from the holding potential of -50 mV from the current response elicited from the holding potential of -90 mV. A3: in the same sensory neuron the voltage-clamp pulses were repeated after bath application of an analogue of CAMP (1 mM 8-br-CAMP) (+cAMP). A4: I* was isolated by subtracting the 2 current responses elicited in the presence of the analogue of CAMP. Comparison of amplitudes of IA isolated in ASW (A2) and isolated in the presence of the analogue of CAMP (A4) indicated that the analogue of CAMP did not reduce the amplitude of the IA. Subsequent increase in the concentration of 8-br-CAMP in the bath to 2 mM did not reduce the amplitude of Z* (data not shown). BI: in a different sensory neuron, current responses were elicited in ASW by voltageclamp pulses to -20 mV from holding potentials of -50 and -90 mV. B2: IA was isolated by subtracting the current response elicited from the holding potential of -50 mV from the current response elicited from the holding potential of -90 mV. B3: voltage-clamp pulses were repeated after bath application of forskolin (50 PM) (+FSK). 84: IA was isolated by subtracting the 2 current responses elicited in the presence of forskolin.
Comparison of the amplitudes of IA isolated in ASW (B2) and isolated in the presence of forskolin (B4) indicated that forskolin reduced the amplitude of IA. Increasing the concentration of forskolin in the bath to 100 PM produced an additional reduction in IA (data not shown). Comparison of effects on IA of the analogue of CAMP (Ad) and forskolin (B4) illustrated that the reduction of 1* by forskolin was not mimicked by the analogue of CAMP.
-J 2 nA 20 ms the presence of forskolin (Fig. 1 B4) , clearly demonstrates that forskolin reduced the amplitude of Z*. The differential effects of the analogue of CAMP and forskolin did not appear to be related to different concentrations of intracellular CAMP. Doubling and tripling the concentration of the analogue of CAMP did not affect the amplitude of Z* (data not shown). However, progressive increases in the concentration of forskolin produced additional reductions in the amplitude of Z* (data not shown). Thus the reduction of Z* by forskolin was not mimicked by analogues of CAMP.
Figure 2 provides evidence that the effect of forskolin on Z* was independent of its ability to activate adenylate cyclase. In four different sensory neurons, Z* was isolated from voltage-clamp pulses to -30, -20, and -10 mV. Z* was isolated first in ASW (Fig. 2 2. Reduction of I* by forskolin was independent of activation of adenylate cyclase. In 4 different sensory neurons, examples of 1* were isolated from voltage-clamp pulses to -30, -20, and -10 mV. Examples of I* were isolated first in ASW (AI, BI, CI, and DI) and again after bath application of either 1 mM 8-br-CAMP (+cAMP, A2), 50 PM forskolin (+FSK, 82), 80 PM 7-deacetyl-6-[N-acetylglycyll-forskolin (+Mod-FSK, Ct), or 50 PM 1,9-dideoxy-forskolin (+Non-FSK, 02). Analogue of CAMP did not affect the amplitude of 1* (compare Al and A2). Similarly, the presence of the 7-deacetyl-6-[N-acetylglycyll-forskolin, which retains the ability to activate adenylate cyclase, did not affect IA (compare Cl and C2). Increasing the concentration of 7-deacetyl-6-[N-acetylglycyl]-forskolin to 160 PM did not affect the amplitude of IA (data not shown). In contrast, both forskolin (B2) and the nonactive form of forskolin, 1,9-dideoxy-forskolin, (02) appeared to be equipotent in reducing the amplitude of IA. Increasing the concentration of 1,9-dideoxy-forskolin to 100 PM produced an additional reduction in the amplitude of IA (data not shown). Thus the amplitude of 1* was not reduced by increased levels of CAMP, and the reduction of 1* by forskolin and 1,9-dideoxy-forskolin appeared to be independent of the activation of adenylate cyclase.
1,9-dideoxy-forskolin (+ Non-FSK, Fig. 202 ). The analogue of CAMP did not affect the amplitude of Z* (compare Fig. 2, Al and A2) . Similarly, the modified form of forskolin that retains the ability to activate adenylate cyclase did not affect the amplitude of Z* (compare Fig. 2, Cl and C2) . Furthermore, subsequent increases in the concentrations of 7-deacetyl-6-[N-acetylglycyll-forskolin had no effect on the amplitude of Z* (data not shown). Thus elevated levels of intracellular CAMP or activation of adenylate cyclase by 7-deacetyl-6-[IV-acetylglycyll-forskolin did not appear to affect Z*. In contrast, forskolin reduced the peak amplitude of Z* (compare Fig. 2, BZ and B2 ). This effect of forskolin was mimicked by a derivative of forskolin that does not activate adenylate cyclase, 1,9-dideoxy-forskolin (compare Fig. 2 , DZ and 02). Furthermore, subsequent increases in the concentrations of either forskolin or 1,9-dideoxy-forskolin produced additional reductions in the amplitude of Z* (data not shown). Thus the effects of forskolin and 1,9-d& deoxy-forskolin on Z* appeared to be independent of activation of adenylate cyclase.
These results are summarized in Fig. 3 . The average peak amplitudes for Z* are plotted at three membrane potentials. As described above, Z* was isolated first in ASW (0) and again after bath application of either analogues of CAMP (Fig. 3A) , forskolin (Fig. 3B) , 7-deacetyl-6-[N-acetylglycyl]-forskolin (Fig. 3C) , or 1,9-dideoxy-forskolin (Fig. 30) . The analogues of CAMP did not affect the average peak amplitude of Z* at any of the membrane potentials examined (Fig. 3A) . Similarly, the modified form of forskolin that retains the ability to activate adenylate cyclase, 7=dea-cetyl-6-[N-acetylglycyll-forskolin, did not affect the average peak amplitude of 1* (Fig. 3C ). Both forskolin (Fig. 3B ) and the nonactive form of forskolin, 1,9-dideoxy-forskolin (Fig. 3D) , however, reduced the amplitude of 1* at each membrane potential. Thus the reduction of 1* by forskolin was not mimicked by elevated levels of CAMP and was independent of activation of adenylate cyclase.
Reduction of I K,v by forskolin not mediated via CAMP
To determine whether CAMP or forskolin affected the voltage-dependent K+ current (1k,v), we examined Ik,v first in ASW and again after bath application of either an analogue of CAMP or forskolin. Figure 4 illustrates the methods used to examine I K,V in relative isolation. Current responses were elicited by voltage-clamp pulses to +20 mV from a holding potential of -50 mV. As illustrated in Fig.  1 , this holding potential inactivated 1*. In addition, 1 mM of the K+ channel blocker TEA was included in the bathing solution throughout the experiment. Previous work has shown that low concentrations of TEA significantly reduce a Ca2+-activated K+ current (1k ca), while having little effect on lk,v (Baxter and Byrne 1989; Hermann and Gorman 198 1; Rudy 1988; Thompson 1977; Walsh and Byrne 1989) . Thus 1 mM TEA was used to reduce the contribution of lk,oa to these current responses. Under these conditions, lk,v is the predominant (but not the only) K+ current in the current responses. (It should be noted that lks is relatively insensitive to TEA and is relatively voltage-independent. In addition, I k s develops slowly during the voltage-clamp pulse. Thus & s, which reaches its peak amplitude at the end of the voltage-clamp pulse, see below, is a component of these current responses.)
The effect of CAMP on lkv was examined by eliciting current responses, which were predominantly 1k v, first in ASW (plus TEA) and again after bath application of an analogue of CAMP (Fig. 4A) . The analogue of CAMP did not affect the peak amplitude of the current response. However, the analogue of CAMP reduced the current response at the end of the voltage-clamp pulse. This decrease in the current response at the end of the pulse represents the reduction of the CAMP-sensitive 1k s (see below). Subsequent increases in the concentration'of the analogue of CAMP neither affected the peak amplitude of the current response nor produced any further decrease in the current response at the end of the voltage-clamp pulse (data not shown). This result suggested that the concentrations of analogues of CAMP used in this study produced a maximal CAMP-mediated response. Because the analogue of CAMP did not affect the peak amplitude of the current response, it appeared that 1 K,V was not reduced by increased levels of CAMP.
In contrast to the analogue of CAMP, bath application of forskolin dramatically reduced the peak amplitude of the current response, which was predominantly lk,v (Fig. 4B ). Subsequent increases in the concentration of forskolin produced further decreases in the peak amplitude of the current response (data not shown). To determine whether this effect of forskolin was related to activation of the adenylate cyclase, we examined the effects of two derivatives of forskolin on these current responses. The modified form of forskolin that retains the ability to activate adenylate cyclase, 7-deacetyl-6-[N-acetylglycyll-forskolin, did not mimic the effect of forskolin on lk,v (Fig. 4C) . Instead, mimicked the effect of the analogue of CAMP and appeared to reduce the CAMP-sensitive 1 K,S (see below). The nonactive form of forskolin, 1,9-dideoxy-forskolin, did mimic the effect of forskolin and reduced the amplitude of the current response (Fig. 40) .
These results are summarized in Fig. 5 . The average peak amplitudes of current responses, which were predominantly 1k,v (see Fig. 4 ), are plotted at three membrane potentials. The current responses were elicited first in ASW (0) and again after bath application of either an analogue of CAMP (Fig. 5A), forskolin (Fig. 5B) , 7-deacetyl-6-[Nacetylglycyll-forskolin (Fig. 5 C) , or 1,9-dideoxy-forskolin (Fig. 5D) . Neither the analogues of CAMP nor the modified form of forskolin, 7-deacetyl-6-[N-acetylglycyll-forskolin, reduced the peak amplitude of the current responses. In contrast, both forskolin and the nonactive derivative of forskolin, 1,9-dideoxy-forskolin, reduced the peak amplitude of the current responses at all membrane potentials. Thus both forskolin and 1,9-dideoxy-forskolin appeared to reduce 1k,v, and this effect of forskolin on 1k,v appeared to be independent of either activation of adenylate cyclase or increased levels of CAMP. (1k,v) . In 4 different sensory neurons, current responses were elicited by voltage-clamp pulses to +20 mV from a holding potential of -50 mV in ASW containing 1 mM TEA. This holding potential inactivated IA (see Fig. l) , and this concentration of TEA was effective in blocking a Ca*+-activated K+ current in these sensory neurons (Baxter and Byrne 1989; Walsh and Byrne 1989) . Thus the predominant component of the outward membrane current under these conditions was 1k,v. Voltage-clamp pulses were repeated after bath application of either 1 mM 8-br-CAMP (+cAMP, A), 50 PM forskolin (+FSK, B), 50 PM 7-deacetyl-6-[N-acetylglycyll-forskolin (+Mod-FSK, C), or 50 PM 1,9-dideoxy-forskolin (+Non-FSK, D). Both the analogue of CAMP and 7-deacetyl-6-[Nacetylglycyll-forskolin reduced the amplitude of the current response at the end of the voltageclamp pulse, while having little or no effect on the peak amplitude of the current response. Increasing the concentrations of the analogue of CAMP to 2 mM, or of 7-deacetyl-6-[N-acetylglycyllforskolin to 200 PM did not produce any further reduction of the peak amplitude of the current response, neither did the increased concentrations produce any further reduction of amplitude of the current response at the end of voltageclamp pulse (data not shown). In contrast, both forskolin and 1,9-dideoxy-forskolin markedly reduced the peak amplitude of current response. Increasing concentrations of forskolin or of 1,9-dideoxy-forskolin to 100 PM produced additional reductions in current responses (data not shown). Thus forskolin appeared to reduce the amplitude of Ik,v, and this action of forskolin was not mimicked by elevated levels of intracellular CAMP.
at least in part, from the phosphorylation of a protein closely related to the S-channel by the CAMP-dependent PKA (Shuster et al. 1985) . This phosphorylation results in the closure of S-channels and thus a reduction in the macroscopic S-current (I,,J (Baxter and Byrne 1989; Belardetti et al. 1987; Brezina et al. 1987; Klein et al. 1980; Pollock et al. 1985; Pollock and Camardo 1987; Scholz and Byrne 1988; Walsh and Byrne 1989) . In this study we observed that 7-deacetyl-6-[N-acetylglycyll-forskolin mimicked the effect of analogues of CAMP and reduced the amplitude of current responses at the end of voltage-clamp pulses (Fig. 4C) . Therefore we wished to determine whether the membrane current modulated by 7-deacetyl-6-[N-acetylglycyll-forskolin was similar to the membrane current that was modulated by analogues of CAMP.
We compared the effects of analogues of CAMP and 7-deacetyl-6-[N-acetylglycyll-forskolin on current responses by isolating CAMP difference currents (IcAMP) and 7-deacetyl-6-[N-acetylglycyll-forskolin difference currents (&&Fsk). An example of the method used to isolate these difference currents is shown in Fig. 6 . The current response that was elicited in ASW by a voltage-clamp pulse from -90 to -20 mV is shown in Fig. 6AI 6B2 ). The properties of ZcAMP and ZModmFSK were similar; both increased slowly during the voltage-clamp pulse, did not inactivate, and were activated over a wide range of membrane potentials. The current-voltage (I-v) relationships for the ZcAMP and ZModmFSK are shown in Fig. 6C . The amplitudes of the difference currents were measured at the end of the voltage-clamp pulse and were plotted such that positive values represent a decrease in the current response at the end of the voltage-clamp pulse. These I-V relationships were nearly identical, and the amplitudes of ZcAMP and ZModmFSK increased nearly linearly with voltage. The properties of ZcAMP and Z Md-Fsk appeared to be similar to those previously described for Zk s (Baxter and Byrne 1989; Belardetti et al. 1987; Brezina et al. 1987; Klein et al. 1980; Klein and Kandel 1982; Pollock et al. 1985; Pollock and Camardo 1987; Walsh and Byrne 1989) . Thus these results suggested that both analogues of CAMP and 7-deacetyl-6-[N-acetylglycyll-forskolin reduced Zk s and indicate that 7-deacetyl-6-[N-acetylglycyll-forskolin 'activated the adenylate cyclase in sensory neurons of Aplysia.
FIG. 5. Reduction of 1 k,v by forskolin was not mediated via CAMP and was independent of activation of adenylate cyclase. Current-voltage (I-v) relationships are shown for the averaged peak amplitude (+SEM) of current responses that were elicited from a holding potential of -50 mV and in the presence of 1 mM of TEA (see Fig. 4 ). Current responses were elicited first in ASW @) (plus 1 mM TEA) and again after bath application of either an analogue of CAMP (+cAMP, A), forskolin (+FSK, B), 7-deacetyl-6-[N-acetylglycyll-forskolin (+Mod-FSK, C), or 1,9-dideoxy-forskolin (+Non-FSK, D). Neither analogues of CAMP nor 7-deacetyl-6-[N-acetylglycyl]-forskolin reduced the peak amplitude of these current responses at any voltage-clamp potentials examined. In contrast both forskolin and 1,9-dideoxy-forskolin reduced the peak amplitude of the current response at all voltage-clamp potentials examined. Thus the reduction of current responses, which were predominantly Ik,v, by forskolin was not mimicked by increased levels of CAMP and was independent of activation of adenylate cyclase.
Dilute solutions of DMSO did not alter current responses
Several lines of evidence indicated that the differential effects on current responses of analogues of CAMP and forskolin were not related to the DMSO that was used to solublize forskolin. First, one of the analogues of CAMP (8-pcpt-CAMP) also was solublized with DMSO. (In a few experiments DMSO also was included in solutions of the 8-br-CAMP analogue of CAMP. The presence of DMSO did not alter the effects of 8-br-CAMP on the current responses.) Second, DMSO was used to solubilize both forskolin and 7-deacetyl-6-[N-acetylglycyll-forskolin, and yet these two compounds had very different effects on current responses. As a final control, we examined whether dilute solutions of DMSO alone had direct effects on current responses. Current responses were elicited first in ASW (Fig.   7 , A and B) and again after bath application of DMSO (Fig.  7, A and B) . The presence of 1% DMSO in the bath had no effect on the current responses. The I-I/relationships of the current responses that were elicited first in ASW and then in the presence of 1% DMSO are shown in Fig. 7C . The presence of 1% DMSO did not reduce the peak amplitude of the current responses at any of the membrane potentials examined. Thus the presence of the DMSO could not account for the observed actions of forskolin or 1,9-dideoxyforskolin. Analogue of CAMP reduced the amplitude of the current response at the end of the voltage-clamp pulse. A2: CAMP difference current (I cAMP) was isolated by subtracting the current response elicited in the presence of the analogue of CAMP from the current response elicited in ASW (a -b). Reduction of the current response by tb analogue of CAMP was represented as an upward deflection in the difference current. Subsequent increase in the concentration of the analogue of CAMP in the bath to 2 mM did not produce any additional reduction in amplitude of the current response (data not shown). BI: in a different sensory neuron, current responses were elicited by voltage-clamp pulses from -90 to -20 mV in ASW (a) and again after bath application of . This modified form of forskolin, which activates adenylate cyclase, mimicked the effect of the analogue of CAMP and reduced the amplitude of the current response at the end of the voltage-clamp pulse. B2: 7-deacetyl-6-[N-acetylglycyll-forskolin difference current (IMti-rsk) was isolated by subtracting the current response elicited in the presence of 7-deacetyl-6-[N-acetylglycyll-forskolin from the current response elicited in ASW (a -b). Increasing the concentration of 7-deacetyl-6-[N-acetylglycyll-forskolin in the bath to 200 PM did not produce any further decrease in amplitude of the current response (data not shown). C: I-V relationships for averaged amplitudes (+SEM) of the CAMP and the 7-deacetyl-6-[N-acetylglycyll-forskolin difference currents (IcAMP and lMod-FSK) are shown. Amplitudes of difference currents were measured at the end of the voltage-clamp pulse. Data are plotted such that a positive value represents a decrease in the amplitude of the current response at the end of the voltage-clamp pulse (e.g., A I and BI). Both the analogue of CAMP and 7-deacetyl-6-[N-acetylglycyll-forskolin reduced a slow component of current responses at all voltage-clamp potentials examined, and both Ic,,, and r,,-rsk were relatively voltage independent. Characteristics of IcAMp and IModwrsK were identical and suggested that both compounds modulated a single class of K+ channels, which has properties similar to 1k,s.
DISCUSSION of
We conclude that in somata of pleural sensory neurons Aplysia forskolin had direct effects on voltage-activated K+ currents that were not mediated via CAMP and that were independent of activation of adenyl ate cyclase. Both forskolin and the nonacti ve derivative of forskolin, 1,9-dideoxy-forskol in, reduced the peak amplitudes of IA and A: current responses were elicited by voltage-clamp pulse from -90 to -20 mV in ASW and again after bath application of 1% DMSO. B: in a different sensory neuron, current responses were elicited by voltageclamp pulses from -50 to t20 mV in ASW and again after bath application of 1% DMSO. Presence of DMSO in the bath had little or no effect on current responses. C: I-V relationships for averaged peak amplitudes of current responses that were first elicited in ASW (0) and again after bath application of DMSO (+ 1% DMSO) are shown (SEM ranged between 2 and 7% of means). DMSO did not alter I-V relationships of current responses. Thus DMSO, which was used to solubilize some compounds used in this study (see METHODS), could not account for the differential effects of analogues of CAMP and forskolin on current responses. Membrane Potential (mv) I whereas analogues of CAMP had no effect on the peak ayplitudes of 1* or 1 k,v. Instead, analogues of CAMP reduced only the previously described CAMP-sensitive & s. These results suggest that neither 1* nor lk v in the somata of pleural sensory neurons are modulated by CAMP. Finally, we observed that a modified form of forskolin, 7-deacetyl-6-[N-acetylglycyll-forskolin, mimicked the effect of analogues of CAMP, and reduced Ik s, but it did not affect the amplitudes of either 1A or Ik,v .'
The mechanism by which forskolin and 1,9-dideoxy-forskolin interact with K+ currents is not known (Laurenza et al. 1989) . A model has been suggested in which forskolin blocks K+ channels in a manner similar to the block of K+ channels by the aminopryidines (Coombs and Thompson 1987; Hoshi et al. 1988; Watanabe and Gola 1987) . In both cases channels appear to activate normally but then quickly inactivate, suggesting that the blocker binds only to the conductive or open state of the channel. Alternatively, it has been suggested that the CAMP-independent effects of forskolin may result from alterations in lipid structure and disruption of membrane structure by the lipophilic diterpene (Joost and Steinfelder 1987; McHugh and McGee 1986) . The results of this study do not distinguish between these models. However, the results do support the suggestion that the lipophilic properties of forskolin contribute to its CAMP-independent effects. The more hydrophilic derivative, 7-deacetyl-6-[N-acetylglycyll-forskolin, did not mimic the CAMPindependent actions of forskolin, whereas the lipophilic nonactive derivative, 1,9-dideoxy-forskolin, did mimic the CAMP-independent effects of forskolin. The results also illustrate that the CAMP-independent effects of forskolin on membrane currents are not identical in all experimental preparations. For example, HarrisWarrick ( 1989) reported that forskolin reduced the amplitude of IA but did not affect either Ik ca or Ik v in somata of neurons in lobsters. In this study, however, we observed dramatic reduction of both 1* and Ik v by forskolin in the somata of sensory neurons of Aalysia.'The CAMP-independent effects of forskolin may not be limited to direct interactions with voltage-activated membrane currents (Laurenza et al. 1989) . For example, forskolin modulates the desensitization of receptors of acetylcholine, but this effect of forskolin is not coupled to its ability to activate adenylate cyclase (Wagoner and Pallotta 1988) . The results presented in this paper and by others indicate that forskolin should not be used as a probe to study the involvement of CAMP in the regulation of neuronal properties. Hydrophilic derivatives of forskolin, which retain the ability to activate adenylate cyclase, however, are attractive pharmacologic tools that do not seem to produce the CAMP-independent effects produced by forskolin.
